76545-3
Breast cancer 10-year risk of distant recurrence classification [Interpretation] Qualitative by Prosigna
Active
Term Description
The risk classification is an ordinal risk category (low, intermediate, high) that indicates a patient's risk of recurrence of breast cancer at 10 years. The classification is based on the 10-year risk of distant recurrence score and lymph node status. Low risk is associated with a 3% chance (confidence interval 2-6%), intermediate risk is associated with a 10% chance (confidence interval 7-14%), and high risk with a 16% chance (confidence interval 11-22%) of distant breast cancer recurrence at 10 years, respectively. PMID: 24347518 This term was created for the Prosigna™ Breast Cancer Prognostic Gene Signature assay, which is intended for use in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), hormone receptor-positive (HR+) breast cancer who have undergone surgery and are to be treated with adjuvant endocrine therapy alone.
LOINC Names Get Info
- Fully-Specified Name
- Breast cancer 10Y risk of distant recurrence classification:
Imp: Pt: ^Patient: Ord: Prosigna - Long Common Name
- Breast cancer 10-year risk of distant recurrence classification [Interpretation] Qualitative by Prosigna
- Short Name
- Brst ca 10Y dist recur class Prosigna
- Display Name
- Breast cancer 10-year risk of distant recurrence classification Prosigna Ql [Interp]
- Consumer Name Alpha Get Info
- Breast cancer 10-year risk of distant recurrence classification
Part Model Get Info
- Component
- Breast cancer 10Y risk of distant recurrence classification
LP188520-3
- Analyte
- Breast cancer 10Y risk of distant recurrence classification
LP188520-3
- Component Numerator
- Breast cancer 10Y risk of distant recurrence classification
LP188520-3
- Component Numerator Core
- Breast cancer 10Y risk of distant recurrence classification
LP188520-3
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Imp
LP6819-9
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- ^Patient
LP310005-6
- System Core
- NULL
- Super System
- Patient
LP6985-8
- Scale
- Ord
LP7751-3
- Method
- Prosigna
LP189616-8
Normative Answer List: LL3198-0
Source: Laboratory Corporation of America| Answer | Code | Score | Answer ID |
|---|---|---|---|
| High risk | LA19541-4 | ||
| Intermediate risk | LA22380-2 | ||
| Low risk | LA19542-2 |
Basic Attributes
- Class
- MOLPATH
- Type
- Laboratory
- First Released
- Version 2.52
- Last Updated
- Version 2.73 (MIN)
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 18127
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 76546-1 | Breast cancer 10-year risk of distant recurrence panel by Prosigna |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Karcinom prsu klasifikace 10letého rizika vzdálené recidivy: |
| el-GR | Greek (Greece) | Κατηγοριοποίηση κινδύνου απομακρυσμένης υποτροπής του καρκίνου του μαστού σε 10 έτη: Synonyms: - Imp MOLPATH Ord Prosigna Pt Ασθενής Καρκίνος Κατηγοριοποίηση κινδύνου απομακρυσμένης υποτροπής του καρκίνου του μαστού σε 10 έτη |
| es-ES | Spanish (Spain) | Clasificación del riesgo de recurrencia a 10 años en el cáncer de mama: |
| es-MX | Spanish (Mexico) | Clasificación de riesgo de recidiva distante 10 años del cáncer de mama: |
| fr-FR | French (France) | Cancer du sein classification des risques de récidive sur 10 ans: |
| it-IT | Italian (Italy) | Tumore della mammella, rischio 10 anni di recidive tumorali, classificazione: Synonyms: Impressione/interpretazione di studio Patologia molecolare paziente Punto nel tempo (episodio) |
| zh-CN | Chinese (China) | 乳腺癌远处转移 10 年风险分类: Synonyms: Prosigna 法 乳腺癌远处转移(远程转移) 10 年风险(危险性、 |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://